PA
ASTX

Pinnacle Associates’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Pinnacle Associates’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-79,820
Closed -$678K – 605
2013
Q3 		$678K Buy
79,820
+64,320
+415% +$407K 0.01% 398
2013
Q2 		$64K Buy
+15,500
New +$83.3K ﹤0.01% 536

Pinnacle Associates's ASTX Position: Q4 2013 in Review

Pinnacle Associates sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 79,820 shares — an estimated $678K sold.

Pinnacle Associates first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $678K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Pinnacle Associates reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Pinnacle Associates sold 79,820 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $678K.
  • Pinnacle Associates first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Pinnacle Associates's ASTEX PHARMACEUTICALS, INC COM position peaked at $678K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Pinnacle Associates's 13F filing for Q4 2013, filed 12 Feb 2014.